FLUGEN, INC.
Biotechnology ResearchWisconsin, United States11-50 Employees
FluGen, Inc. is a clinical-stage vaccine company transforming vaccine efficacy in respiratory diseases.
Innovative Vaccine Platform FluGen's development of the M2SR technology and its focus on improving flu vaccine efficacy present opportunities for collaborations with healthcare providers and public health agencies interested in next-generation respiratory vaccines.
COVID-19 and Flu Combination The company's pursuit of a combined COVID-19 and influenza vaccine positions it to engage with healthcare systems and government programs seeking versatile vaccination solutions for seasonal and pandemic preparedness.
Government Funding Leverage With significant funding from the U.S. Department of Defense for flu vaccine research, FluGen may benefit from outreach to defense and military health sectors interested in advanced respiratory disease protection.
Recent Efficacy Boosts Recent trials showing intranasal flu vaccine efficacy improvements can open pathways to partnerships with clinics and health organizations aiming to enhance vaccine performance and public health outcomes.
Growing Financial Backing FluGen's substantial funding and moderate revenue levels present a compelling opportunity for investors and biotech partners looking to support innovative vaccine development and expand manufacturing capacity.
FLUGEN, INC. uses 8 technology products and services including Twemoji, jQuery, Google Maps, and more. Explore FLUGEN, INC.'s tech stack below.
| FLUGEN, INC. Email Formats | Percentage |
| FLast@flugen.com | 46% |
| First_Last@flugen.com | 4% |
| FLast@flugen.com | 46% |
| First_Last@flugen.com | 4% |
Biotechnology ResearchWisconsin, United States11-50 Employees
FluGen, Inc. is a clinical-stage vaccine company transforming vaccine efficacy in respiratory diseases.
FLUGEN, INC. has raised a total of $62M of funding over 6 rounds. Their latest funding round was raised on Jul 01, 2021 in the amount of $11Mas a US Defense Department funding.
FLUGEN, INC.'s revenue is estimated to be in the range of $10M$25M
FLUGEN, INC. has raised a total of $62M of funding over 6 rounds. Their latest funding round was raised on Jul 01, 2021 in the amount of $11Mas a US Defense Department funding.
FLUGEN, INC.'s revenue is estimated to be in the range of $10M$25M